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Retrotransposition of L1 LINEs (long interspersed elements) continues to sculpt the human genome. However,
because recent insertions are dimorphic, they are not fully represented in sequence databases. Here, we have
developed a system, termed “ATLAS” (amplification typing of L1 active subfamilies), that enables the selective
amplification and display of DNA fragments containing the termini of human-specific L1s and their respective
flanking sequences. We demonstrate that ATLAS is robust and that the resultant display patterns are highly re-
producible, segregate in Centre d’Etude du Polymorphisme Humain pedigrees, and provide an individual-specific
fingerprint. ATLAS also allows the identification of L1s that are absent from current genome databases, and we
show that some of these L1s can retrotranspose at high frequencies in cultured human cells. Finally, we demonstrate
that ATLAS also can identify single-nucleotide polymorphisms within a subset of older, primate-specific L1s. Thus,
ATLAS provides a simple, high-throughput means to assess genetic variation associated with L1 retrotransposons.
Introduction
L1 LINEs (long interspersed elements) are abundant
non–long-terminal-repeat retrotransposons that com-
prise ∼17% of human DNA (Lander et al. 2001). The
vast majority of L1s retrotransposed in the distant past
and continued to accumulate mutations at the pseudo-
gene rate. Thus, these ancient L1 insertions generally
are fixed with respect to presence in human populations
and are retrotransposition defective (Smit et al. 1995;
Lander et al. 2001). In contrast, the average human
genome contains ∼60–100 retrotransposition-compe-
tent L1s (RC-L1s) (Sassaman et al. 1997; Moran and
Gilbert 2002), and many of them are dimorphic, in-
dicating that they have retrotransposed since the origin
of our species (Sheen et al. 2000; Ovchinnikov et al.
2001; Myers et al. 2002).
RC-L1s are 6.0 kb in length and contain a 5′ UTR,
two nonoverlapping ORFs (ORF1 and ORF2), and a
3′ UTR that ends in a poly(A) tail (Scott et al. 1987;
Dombroski et al. 1991). ORF1 encodes a 40-kDa nu-
cleic acid binding protein (ORF1p) (Holmes et al. 1994;
Hohjoh and Singer 1996; Hohjoh and Singer 1997),
whereas ORF2 encodes a protein (ORF2p) with both
endonuclease and reverse-transcriptase activities (Ma-
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thias et al. 1991; Feng et al. 1996). Both ORF1p and
ORF2p are required for retrotransposition (Moran et
al. 1996), which likely occurs by a mechanism termed
“target-site–primed reverse transcription” (Luan et al.
1993; Luan and Eickbush 1995; Feng et al. 1996;
Moran et al 1996).
L1 retrotransposition continues to have an impact on
the human genome. To date, 14 de novo insertions have
been identified that have resulted in either a genetic dis-
order or a novel polymorphism (for review, see Moran
1999; Moran and Gilbert 2002). Sequence analysis has
demonstrated that 13 insertions have an ACA trinucle-
otide at positions 5930–5932 of their 3′ UTR (relative to
L1 retrotransposable element 1) (Dombroski et al. 1991)
(fig. 1a), which is diagnostic for the youngest human L1
subfamily (i.e., the Ta subfamily) (Skowronski et al.
1988). The remaining insertion contains an ACG tri-
nucleotide at this position within its 3′ UTR, which is
diagnostic for the slightly older, pre-Ta subfamily (Ka-
zazian et al. 1988; Boissinot et al. 2000; Lander et al.
2001). The development of a cultured-cell retrotransposi-
tion assay subsequently confirmed that the Ta subfamily
comprises the majority of human RC-L1s (Moran et al.
1996; Sassaman et al. 1997; Kimberland et al. 1999).
The L1 Ta subfamily is specific to humans (Boissinot
et al. 2000) and consists of ∼535 members that ampli-
fied during the past 2 million years (Lander et al. 2001;
Myers et al. 2002). Approximately 160 Ta-subfamily
L1s are full length, and phylogenetic analyses have dem-
onstrated that they can be divided into two groups (the
older is termed “Ta-0,” and the younger is termed “Ta-
1”) on the basis of the presence of diagnostic nucleotides
at positions 5536 and 5539 of ORF2 (Boissinot et al.
2000). In addition, full-length Ta-1 L1s can be sub-
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Figure 1 Principle of ATLAS. a, Overview of LI structure. A schematic of a full-length Ta-1d L1 retrotransposon indicates the position
of 5′ and 3′ UTRs, ORFs, and Ta-1d–specific and Ta-subfamily–specific primers. b, Principle of ATLAS, as depicted by a flow chart of the
ATLAS procedure. Digestion of genomic DNA and ligation to a GC-rich oligonucleotide linker create a library of fragments flanked by defined
sequences (A–C) (top). The denatured single-stranded DNA can self-anneal within the common linker sequences to form a frying pan–shaped
intermediate that is inefficiently amplified (A and B). By contrast, subfamily-specific L1 primers can anneal within the frying pan (C), leading
to extension products containing a single linker, which subsequently can undergo exponential amplification (bottom). Black bars indicate genomic
DNA sequence, white bars indicate L1 sequence, and speckled bars indicate linker sequences. Restriction sites (R) that are compatible with the
linker and the L1-specific (L1) and linker-specific (X) primers are shown.
classified on the basis of the presence (Ta-1nd) or ab-
sence (Ta-1d) of a single guanosine nucleotide at posi-
tion 72 of their respective 5′ UTRs (Boissinot et al. 2000)
(fig. 1a). Because the allele frequency of an individual
L1 generally is correlated with its age, Ta-subfamily L1s
consistently comprise most of the dimorphic L1s in the
human genome. For example, ∼30% of Ta-0 L1s are
dimorphic, whereas ∼56% of Ta-1 L1s are dimorphic
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Table 1
Summary Statistics of a Full-Length Human-Specific L1 Database
L1 Subfamily Totala
TSDs
Identifiedb
TSDs
Unidentifiedc
ORF1/ORF2
Intactd
ORF1/ORF2
Interruptede
Ta 144 137 7 64 80
Pre-Ta 86 83 3 27 59
Non-Ta 22 19 3 3 19
Other 4 4 0 2 2
Total 256 243 13 96 160
The full database is available online, at the authors’ Web site.
a Total number of L1s, from each subfamily, meeting the selection criteria.
b Number of L1s that are flanked by TSDs located within 5 kb of flanking DNA.
c Number of L1s that are not flanked by TSDs.
d Number of L1s from each respective subfamily with intact ORFs.
e Number of L1s in which either ORF1 and/or ORF2 contain chain-termination mutations.
(Boissinot et al. 2000). Thus, although the Ta subfamily
comprises only ∼0.1% of human L1s, its members rep-
resent a valuable source of identical-by-descent markers
that can be used in population studies (Sheen et al. 2000;
Ovchinnikov et al. 2001; Myers et al. 2002).
PCR-based procedures previously have been developed
to identify dimorphic retrotransposon insertions in hu-
man DNA. For example, L1 display, which utilizes PCR
primers specific to subfamilies of L1s, has been success-
ful in the identification of candidate dimorphic L1 inser-
tions (Sheen et al. 2000; Ovchinnikov et al. 2001). Simi-
larly, suppression PCR (Lavrentieva et al. 1999) has been
combined with both differential and subtractive hybrid-
ization, to identify human-specific endogenous retrovirus
insertions (Buzdin et al. 2002; Mamedov et al. 2002).
However, though effective, both of these methods are
labor intensive and are not readily amenable to high-
throughput analysis.
Here, we report the development of a system, termed
“ATLAS” (amplification typing of L1 active subfamilies),
that combines the principles employed in suppression
PCR and L1 display. We demonstrate that ATLAS en-
ables the selective amplification and display of human-
specific L1s and that the resultant display patterns are
highly reproducible, segregate in CEPH pedigrees, and
are unique to a given individual. Moreover, ATLAS en-
ables the identification of RC-L1s that are absent from
current genome databases and has allowed the discovery
of SNPs associated with a subset of older, primate-spe-
cific L1s. Thus, ATLAS is a powerful system to assess
genetic variation associated with L1 retrotransposons.
Material and Methods
Oligonucleotides
The oligonucleotides used in the present study (table
S1 [online only, at the authors’ Web site]) were purchased
from Invitrogen and were purified by ethanol precipita-
tion prior to quantification by UV spectrophotometry.
The linker primers were purified by high-performance
liquid chromatography.
A Database of Young Full-Length L1 Insertions
BLAST searches (Altschul et al. 1990) of nonredundant
human genomic databases with a full-length RC-L1 (L1.3
[GenBank accession number L19088]) (Dombroski et al.
1993; Sassaman et al. 1997) were performed to identify
sequence contigs that contain full-length Ta-subset L1s.
The FASTA alignment algorithm (Pearson and Lipman
1988) was used to identify sequences with 198% sequence
identity, over 5,922 colinear bases (allowing a maxi-
mum 5′ truncation of 100 bp) when aligned with L1.3
(GenBank accession number L19088). The database was
rendered nonredundant by exhaustive pairwise compar-
isons utilizing the full-length L1 and 1,000 bp of its 5′
and 3′ flanking sequences. Sequences displaying 195%
identity within either flank were discarded. Each sequence
was annotated with respect to typical L1 structural hall-
marks (i.e., insertion at a consensus endonuclease cleavage
site, presence and position of short direct target-site du-
plications [TSDs], simple or composite poly(A) tail struc-
tures, ORF status, and subfamily diagnostic SNP status).
For L1s present in contigs that are not of “finished”
sequence quality, completion status was monitored reg-
ularly. Summary statistics for the database (available at
the authors’ Web site) are illustrated in table 1. The 256
L1 sequences satisfying these criteria were aligned using
the Clustal W algorithm (Thompson et al. 1994), and
the multiple alignment was manually refined using the
Seaview editor (Galtier et al. 1996), at the Human Ge-
nome Mapping Project Resource Centre. For the full L1
sequence alignment, see the supplementary data avail-
able online, at the authors’ Web site.
DNA Isolation and Sequence Analysis
Plasmid DNAs were purified on Qiagen midi prep col-
umns. BigDye Terminator Cycle Sequencing (ABI Prism)
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was performed on an Applied Biosystems DNA sequencer
(ABI 377 or ABI 3700) at the University of Michigan
Sequencing Core facilities.
PCR Containment Procedures
To maintain PCR hygiene, we prepared and manipu-
lated all reagents in a Class II flow hood (Forma) with
UV (354 nm) decontamination facilities. The hood was
housed outside the laboratory, and caution was taken to
exclude L1-containing PCR products and L1-containing
clones from the hood and its immediate environment. All
manipulations were conducted with equipment that reg-
ularly was UV decontaminated.
Suppression Library Construction and Amplification
Genomic DNA (600 ng) was digested to completion
with 20 U of AseI (NEB) overnight at 37C. Heating at
65C for 20 min inactivated the enzyme, and 100 ng of
the digested DNA was ligated to a 40-fold molar excess
of the annealed suppression linker (RBMSL2) (table S1
[online only, at the authors’ Web site]). The linkers were
annealed by heating equal volumes (20 mM) of RBMSL2
and RBD3 at 65C for 10 min and allowing them to
slowly cool to room temperature. Ligations were per-
formed overnight at 14C–16C in 1 # NEB3 (50 mM
of Tris HCl [pH 7.9], 10 mM of MgCl2, 100 mM of
NaCl, and 1 mM of dithiothreitol) supplemented with
1 mM of ATP and 400 U of T4 DNA ligase. Heating
at 65C for 20 min inactivated the ligase and melted
away the “dummy” RBD3 oligonucleotide (see table S1
[online only, at the authors’ Web site]). Excess linkers
and DNA fragments that were too short (i.e., !100 bp)
to contain flanking genomic sequences were removed
using the Qiaquick PCR purification system (Qiagen).
Approximately 2.5–5 ng of ligated genomic DNA then
was amplified in a 15-ml reaction volume containing
1.25 mM of either RB5PA2 (5′ ATLAS) or RB3PA1 (3′
ATLAS), 1.25 mM of RBX4 (linker-specific primer), 0.5
U of Taq DNA polymerase (Sigma), and 1# PCR buffer
(50 mM of Tris HCl, 12 mM of NH4SO4, 5 mM of
MgCl2, 7.4 mM of 2-mercaptoethanol, 125 mg/ml of
BSA, and 1.1 mM of dNTPs). Amplification was per-
formed, in a Perkin-Elmer 9600, under the following
cycling conditions: 1 cycle at 96C for 2 min; followed
by 30 cycles at 96C for 30 s, 64C for 30 s, and 72C
for 1 min; and a final extension at 72C for 10 min.
In addition to AseI, library ligations were optimized
for use with AciI-, MseI-, and TaqI-digested genomic
DNA (with appropriately modified linkers). Whereas all
figures (1–6) present data derived from AseI-generated
libraries, some of the ATLAS clones subjected to se-
quence analysis were derived from genomic DNA di-
gested with these other enzymes (see table S2 [online
only, at the authors’ Web site]).
Optimization of Suppression PCR
To maximally enrich for human-specific L1s, we op-
timized the suppression PCR. Since the suppression
effect is temperature dependent, we could not simply
raise the primer-annealing temperature to optimize the
reaction. Thus, we successively 5′ truncated the L1-
specific primers used in ATLAS, to determine the min-
imum primer length required in order to selectively
amplify a locus-specific product that resided either
upstream (5′ ATLAS) or downstream (3′ ATLAS) of
a known Ta-1d L1. The desired 5′ product was ampli-
fied only when RB5PA, RB5PA1, or RB5PA2 was used
as a primer (data not shown). Similarly, the desired
3′ product was amplified only when either RB3PA or
RB3PA1 was used as a primer (data not shown). Thus,
all subsequent 5′ ATLAS reactions were conducted with
RB5PA2, and all 3′ ATLAS reactions were conducted
with RB3PA1. We also selected the linker primer (RBX4)
that amplified the desired product most efficiently, and
it was used in all subsequent ATLAS reactions. (For
primer details, see table S1 [online only, at the authors’
Web site].)
Optimization reactions were fractionated on 2% aga-
rose gels, and the products were transferred, by Southern
blotting, to nylon filters (Nytran; Schleicher and Schuell).
DNA was fixed to the membrane by baking at 80C for
2 h. The filters were hybridized to a-32P–labeled (Redi-
prime II; Amersham Pharmacia) unique sequence probes
derived from the empty allele of the locus. Hybridiza-
tion reactions (at 65C) were performed overnight in
7% SDS, 1 mM of EDTA (pH 8.0), and 0.5 M of di-
sodium phosphate/sodium dihydrogen phosphate buffer
(pH 7.2) (Church and Gilbert 1984). Filters were washed
at 65C, twice in 0.2 # SSC (300 mM NaCl and 30
mM sodium citrate) and 0.5% SDS for 15 min and once
in 0.1# SSC (150 mM NaCl and 15 mM sodium citrate)
and 0.1% SDS for 30 min. Radioactive signals were vi-
sualized by autoradiography. Notably, this procedure en-
abled the detection of single-copy sequences from 2.5–5
ng of input genomic DNA, an enrichment of2,000-fold
(relative to a genomic Southern blot input of 10 mg).
Labeling and Display of ATLAS Products
Seventy-five picomoles of the original amplification
primer (RB5PA2 or RB3PA1) was labeled in a 20-ml
reaction volume containing 50 mCi of g-33P ATP and 10
U of T4 DNA kinase at 37C for 60 min. Treatment at
65C for 20 min inactivated the kinase, and the unin-
corporated radioisotope was removed using Sephadex
G-25 spin columns (Amersham Pharmacia). Aliquots of
the labeled primer (0.9–1.9 pmol) were subsequently
used in linear amplifications, to generate the ATLAS dis-
play products. Labeling reactions were conducted in 9-
ml reaction volumes containing 10 mM of Tris HCl (pH
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8.3), 50 mM of KCl, 1.5 mM of MgCl2, 250 mM of
dNTPs, 0.2 U of Taq DNA polymerase (Sigma), and 1
ml of the primary PCR product. Linear amplification was
performed using the following cycling conditions: 1 cycle
at 96C for 2 min; followed by 60 cycles at 96C for 30
s, 64C for 30 s, 72C for 90 s; and a final extension at
72C for 10 min. Five microliters of the resultant prod-
ucts were mixed with 5 ml of sequencing stop mix (95%
formamide, 20 mM EDTA, 0.05 % bromophenol blue,
and 0.05% xylene cyanol FF), and the mixture was de-
natured at 85C for 4 min. Two microliters of the de-
natured products were resolved on 5.0% Long Ranger
(Flowgen), 1 # glycerol–tolerant (Amersham Pharma-
cia) polyacrylamide gels containing 50% urea, and the
dried gel was visualized by autoradiography.
Recovery and Cloning of ATLAS Products
Alignment between the dried gel and the auto-
radiograph containing the ATLAS display products
was achieved using radioactive (33P) ink spots. ATLAS
products were excised from the gel by cutting through
the film and gel, using sterile scalpel blades. Gel frag-
ments were placed in 20–40 ml of buffer (1 mM Tris
HCl [pH 8.0]) and were frozen at 20C. The gel was
reautoradiographed to ensure that the correct prod-
uct was excised, and the thawed gel fragments sub-
sequently were reamplified by adding 1 ml of the eluate
to 20-ml PCRs. The resultant products were separated
on a 2% agarose gel, were purified using the Qiaquick
gel extraction kit (Qiagen), and were cloned using the
pGEM-T easy kit (Promega). DNAs from clones con-
taining insertions were sequenced using the T7 or SP6
oligonucleotide primers. Clone sequence identifiers, as
well as their corresponding accession numbers, are giv-
en in table S2 (online only, at the authors’ Web site).
Confirmation of Dimorphic Status
DNA sequences flanking dimorphic 5′ ATLAS display
products were identified within the December 2001 freeze
of the human genome working draft (HGWD) sequence
by using the BLAT server (Kent 2002), at the UCSC Ge-
nome Bioinformatics Web site. Genomic sequence data
were used to design PCR primers 5′ of the AseI site and
3′ of the predicted L1 insertion site. Two PCRs were used
to determine the insertion status of a given L1 in DNAs
from the 10 individuals used in the original ATLAS anal-
ysis. Cycling conditions were as follows: 1 cycle at 96C
for 2 min; followed by 30 cycles at 96C for 30 s, 64C
for 30 s, and 72C for 90 s; and a final extension at 72C
for 10 min.
Linkage Analysis
Dimorphic full-length L1 insertions identified by
5′ ATLAS in CEPH family 1331 were located in the
HGWD sequence by using BLAT (Kent 2002), and
flanking STR markers were acquired using the NCBI
Map Viewer human genome utility (see the Entrez Ge-
nome View Web site). Segregation data for these loci
were downloaded from the CEPH-Ge´ne´thon Web site.
L1 insertion status was coded as a dominant trait, and
evidence for single-point linkage to each STR marker
was tested using the Fastlink program (Cottingham et
al. 1993), at the Human Genome Mapping Project
Resource Centre.
Amplification and Cloning of Full-Length L1
Retrotransposons
Fifty to five hundred nanograms of genomic DNA
from an individual carrying a given insertion was sub-
jected to long-range PCR amplification with the Ex-
pand Long Template PCR kit (Roche), using primers
complementary to sequences that flank the L1. Con-
ditions and cycling parameters were performed as rec-
ommended by the kit manufacturer. PCR products
were purified and cloned into the pGEM-T easy clon-
ing vector (Promega). The cloned L1s were restricted
with NotI and BstZ17I, and the resultant fragment
was used to replace the corresponding fragment from
pJM102/L1.3. The presence of a full-length L1 in
pCEP4 was verified by restriction mapping and by
sequencing of the 5′ and 3′ ends of the L1 insert.
L1 Retrotransposition Assay
HeLa cells were grown at 37C in an atmosphere
containing 7% carbon dioxide and 100% humidity in
Dulbecco’s modified Eagle medium (DMEM) lacking
sodium pyruvate (Gibco BRL). DMEM was supple-
mented with 10% fetal calf serum and 1 # penicillin-
streptomycin-L-glutamine (100 # stock; Gibco BRL).
Cell passage was performed using standard techniques,
and retrotransposition was monitored using the tran-
sient retrotransposition assay (Wei et al. 2000, 2001).
Results
Principle of ATLAS
We initially sought to develop a system that would
allow us to selectively discriminate human-specific L1s
from the vast majority of older L1s present in the genome.
To accomplish this goal, we combined the principles em-
ployed in L1 display (Sheen et al. 2000) and suppression
PCR (Lavrentieva et al. 1999; Buzdin et al. 2002; Ma-
medov et al. 2002), to develop ATLAS (as outlined in
fig. 1b). First, genomic DNA is digested to completion
with a restriction endonuclease (denoted by “R” in fig.
1b), to generate a subset of DNA fragments that contain
the 5′ and 3′ termini of L1s, as well as their immediate
flanking genomic sequences. The digested DNA is ligated
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to a GC-rich oligonucleotide linker, creating a library of
small DNA fragments (typically 100–1,000 bp), which
are used as templates in PCRs containing both L1- and
linker-specific oligonucleotide primers. Intramolecular
annealing of the terminal-linker sequences suppresses the
amplification of non–L1-containing templates by form-
ing “frying pan”–shaped intermediates. This suppres-
sion effect (Lavrentieva et al. 1999) can be relieved if
an L1-specific primer anneals within the loop of the fry-
ing pan (fig. 1b, right-hand side). The resultant ampli-
cons contain only a single terminal linker and therefore
can undergo exponential amplification in subsequent cy-
cles of PCR, leading to an enrichment of L1 termini and
their immediate flanking sequences. Then, aliquots of
the primary PCR products are used as templates in linear
PCRs containing a 33P-labeled subfamily-specific L1 ol-
igonucleotide. Fractionation of the radiolabeled exten-
sion products on denaturing polyacrylamide gels, fol-
lowed by autoradiography, results in a bar code–like
display of fragments containing L1s and their immedi-
ate flanking sequences.
Results from a Typical ATLAS Experiment
A typical ATLAS experiment conducted with AseI-di-
gested genomic DNA from three unrelated individuals is
shown in figure 2. A primer (RB5PA2) specific for the Ta-
1d diagnostic SNP in the L1 5′ UTR was used to generate
the 5′ display products, whereas a primer (RB3PA1) spe-
cific for the Ta-subfamily sequence present in the L1 3′
UTR was used to generate the 3′ display products (for
primer details, see table S1 [online only, at the authors’
Web site]). The presence of a band indicates that an in-
dividual is either homozygous or hetero-/hemizygous for
the presence of an L1 insertion. The absence of a band
indicates that an individual either lacks the L1 insertion
or contains a sequence-specific variant within either the
oligonucleotide primer-annealing site or the restrictionsite
used in the construction of the ATLAS library.
Comparison of the display products between individu-
als revealed variant and invariant bands. Invariant bands
(see “A” and “C” in fig. 2) indicate candidate L1 inser-
tions that are present in all three individuals. By contrast,
variant bands (see “B” and “D” in fig. 2) indicate can-
didate dimorphic L1 insertions. As expected, the 3′ display
products were more numerous than the 5′ display prod-
ucts, because ∼60% of young L1s are 5′ truncated and
lack the L1 5′ UTR (Boissinot et al. 2000). Band broad-
ening also is observed in the 3′ display products, which
likely results from “stuttering” at the L1 poly(A) tail dur-
ing amplification. Notably, we detected more invariant
bands than anticipated in the 5′ display, but the reason
for this result was elucidated in subsequent experiments
(see the subsection “5′ ATLAS Can Identify Genetic Var-
iation Associated with a Subset of Older, Primate-Specific
L1s,” below).
As controls for reaction specificity, we demonstrated
that the ATLAS display products are dependent on the
presence of input DNA (fig. 2, lanes 5 and 8), restriction-
enzyme digestion (fig. 2, lane 4), ligation (fig. 2, lane 6),
and the presence of the linker (fig. 2, lane 7). Product
characterization revealed that the reproducible banding
pattern observed in the absence of the restriction enzyme
results from inter-L1 PCR amplification (data not shown).
By contrast, the banding patterns observed in the absence
of either ligase (fig. 2, lane 6) or linkers (fig. 2, lane 7)
are stochastic and likely result from rare mispriming
events in the primary PCR. Importantly, reproducible
ATLAS patterns were generated only when all the com-
ponents (genomic DNA, restriction enzyme, ligase, and
linkers) were present in the reactions.
ATLAS Is Reproducible and Robust
To test whether ATLAS was reproducible, we used
two independent AseI-digested genomic DNA samples
from two unrelated individuals as templates in individ-
ual ATLAS reactions (fig. 3a). At each step during the
ATLAS procedure (ligation, suppression PCR, and la-
beling PCR), reactions were prepared in duplicate. The
resultant ATLAS display patterns for each respective
DNA are identical (fig. 3a), indicating that ATLAS is
highly reproducible.
Restriction-based library-construction methods also
can be sensitive to DNA quality, since the effective copy
number of a “target” sequence is dependent on the
mean DNA fragment size. We hypothesized that the
utilization of suppression PCR over small distances
(100–1,000 bp) should minimize the effect that DNA
quality has on the ATLAS display pattern. To test this,
we performed duplicate ATLAS reactions on genomic
DNAs of differing quality from 10 unrelated individ-
uals (fig. 3b). Despite considerable variation in DNA
quality (e.g., see fig. 3b, sample 3), the display patterns
are quantitatively and qualitatively comparable, indi-
cating that ATLAS is robust.
3′ ATLAS Selectively Amplifies Human-Specific L1s
To determine whether ATLAS truly enriches for hu-
man-specific L1 insertions, we cloned and sequenced 19
dimorphic 3′ ATLAS display products that were absent
from at least 1 of the 10 DNAs examined in figure 3b.
Each product had the predicted structure because it con-
tained the 3′ end of a Ta-subfamily L1, a poly(A) tail,
and flanking genomic DNA (tables 2 and S2 [online only,
at the authors’ Web site]).
Next, we used BLAT to map the location of each of
the flanking sequences in the HGWD. In 5 of 19 instances,
the 3′ flanking sequences were located downstream of a
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Figure 2 Representative ATLAS array. Two independent ATLAS display patterns from the DNAs from three unrelated individuals (lanes
1–3) were generated with primers specific to either the 5′ UTR L1 Ta-1d subfamily (left) or the 3′ UTR L1 Ta subfamily (right). The libraries
were labeled in duplicate, resulting in four display lanes per individual. Lane 4 reactions were conducted in the absence of restriction digestion;
lane 5 reactions were conducted in the absence of genomic DNA; lane 6 reactions were conducted in the absence of T4 DNA ligase; lane 7
reactions were conducted in the absence of linker; and lane 8 reactions were conducted in the absence of primary amplification products. “A”
and “C” indicate invariant bands, whereas “B” and “D” indicate variant bands. Size standards are indicated to the left of the gel.
known Ta-subfamily L1. In 3 of 19 instances, there was
no L1 upstream of flanking sequence, suggesting that the
preintegration site (i.e., the sequence lacking the L1 in-
sertion) actually is present in the HGWD. Finally, in 11
of 19 instances, we were unable to unambiguously map
the 3′ flanking sequences, because (1) they were absent
from the HGWD (in five cases); (2) they were composed
of high-copy-number repeats (in three cases: two L1s were
flanked by a-satellite DNA, and one L1 was flanked by
an Alu element); or (3) they were too short to be assigned,
because the restriction site used to create the 3′ display
library was located within 10 bp of the L1 poly(A) tail
(in three cases). Thus, our data indicate that 3′ ATLAS
selectively displays Ta-subfamily L1s and that it enables
the identification of human-specific L1 insertions that
are absent from the HGWD (also see the subsection “5′
ATLAS Identifies Human-Specific L1s,” below).
5′ ATLAS Identifies Human-Specific L1s
To assess the fidelity of 5′ ATLAS, we cloned and se-
quenced 56 dimorphic display products and mapped their
respective 5′ flanking sequences to the HGWD. As above
(see the subsection “3′ ATLAS Selectively Amplifies Hu-
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Figure 3 ATLAS’s reproducibility and robustness. a, High reproducibility. Genomic DNA samples (D1 and D2) from two unrelated
individuals were digested, in duplicate, with AseI, and each digestion was ligated, in duplicate, to a compatible linker (L1–L4). Each of the
purified ligation reactions (A1–A8) was amplified in duplicate, and the resultant primary amplifications (L1–L16) were radiolabeled in duplicate.
The resultant ATLAS display patterns are shown for each of the 16 replicates. b, Robustness. Top, 5′ ATLAS performed, in duplicate, on 10
unrelated individuals (lanes 1–10). Controls (lanes 11–15) are the same as in figure 2. Bottom, Genomic DNAs (∼500 ng), used to generate
the above 5′ ATLAS display patterns, resolved on a 0.8% agarose gel that contained ethidium bromide. Note the significant amount of degradation
in the DNA sample from individual 3. MW p molecular weight markers; l DNA p genomic DNA from bacteriophage lambda.
man-Specific L1s”), in 9 of 56 instances, we were unable
to unambiguously map the 5′ flanking sequences, because
(1) they were absent from the HGWD (in three cases);
(2) they were composed of high-copy-number repeats (in
two cases: one L1 was flanked by a-satellite DNA, and
another L1 was flanked by human satellite II DNA); or
(3) they were too short to be assigned, because the re-
striction site used to create the 5′ display library was lo-
cated within 10 bp of the L1 terminus (in four cases). The
L1 sequences present in these nine clones show high iden-
tity to L1.3, indicating that they likely are derived from
Ta-1d L1s.
In 47 of 56 instances, the flanking sequences could
be unambiguously identified in the HGWD, and, in 23
instances, the display products had the predicted struc-
ture and contained the 5′ end of a Ta-1d L1 and its
flanking genomic DNA. Of those L1s, 8 were present
in the HGWD, whereas 15 were not (tables 2 and S2
[online only, at the authors’ Web site]). The other 24
of these 47 cases are described later (see the subsection
“5′ ATLAS Can Identify Genetic Variation Associated
with a Subset of Older, Primate-Specific L1s,” below).
Independent Verification of the Dimorphic Status
of Human-Specific L1s Identified by 5′ ATLAS
To verify that 5′ ATLAS truly identifies dimorphic Ta-
1d L1s, we used conventional PCR analyses to indepen-
dently assess the presence/absence status of 9 of the 23
full-length L1s identified above (see the subsection “5′
ATLAS Identifies Human-Specific L1s”) (table 3). Am-
plification using 5′ and 3′ flanking primers or a 3′ flanking
primer and a Ta-subfamily specific primer (fig. 4a) en-
abled the discrimination of all possible insertion states
in two PCRs. Typing of the nine loci in 10 unrelated
individuals confirmed the ATLAS results (fig. 4b and
data not shown).
Geographic Distribution of Human-Specific L1s
Identified by 5′ ATLAS
To determine their prevalence and distribution, we
used PCRs to type the nine dimorphic full-length L1
insertions identified above (see the subsection “Indepen-
dent Verification of the Dimorphic Status of Human-
Specific L1s Identified by 5′ ATLAS”) in 90 randomly
selected individuals representative of worldwide human
populations. The panel comprises genomic DNAs from
30 Africans/African Americans, 20 Asians, 20 northern
Europeans, and 20 South Americans. Each locus was
tested for deviation from Hardy-Weinberg equilibrium
(HWE) by a permutation-test method (Guo and Thomp-
son 1992), using the Arlequin population genetics soft-
ware suite (Schneider et al. 2000). After a Bonferroni
correction, none of the loci showed a significant devia-
tion in any population, indicating that they are in HWE.
As expected, the allele frequency of an L1 identified by
5′ ATLAS was correlated with the occurrence of the in-
sertion in the HGWD (table 3). Furthermore—consistent
with the recent origin of low-allele-frequency insertions—
two L1s (ACO11092 and AC087224) were restricted to
particular populations, whereas a third L1 (AL021407)
represented a private polymorphism, which was present
only in a single individual (table 3). Thus, as with 3′
ATLAS, we conclude that 5′ ATLAS enables the ampli-
fication of human-specific L1 insertions and that some
of those L1s are absent from the HGWD.
Some Low-Insertion-Frequency Polymorphic Ta-1d L1s
Are Retrotransposition Competent
We hypothesized that some of the newly identified
Ta-1d full-length L1s should remain retrotransposition
competent. To test this hypothesis, we examined seven
L1s for their ability to retrotranspose in cultured hu-
man HeLa cells. Three L1s (AL358779, AL121819,
and AL021407) (table S2 [online only, at the authors’
Web site]) retrotransposed at levels similar to L1.3 (Gen-
Bank accession number L19088), a known active ele-
ment (table 3), whereas two other L1s (AC008826 and
AC087224) reproducibly retrotransposed at extremely
low (∼0.1%) levels. Thus, ATLAS allows the identifi-
cation of RC-L1s that are absent from the HGWD.
Moreover, since AL021407 was present only in a single
individual (table 3; also see the subsection “Geograph-
ic Distribution of Human-Specific L1s Identified by 5′
ATLAS,” above), our data are consistent with previous
studies, which have showed that recent mutagenic L1
insertions retain the ability to retrotranspose (Naas et
al. 1998; Kimberland et al. 1999).
5′ ATLAS Banding Patterns Segregate in Families
In principle, ATLAS display patterns should exhib-
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Table 2
Characterization of ATLAS Display Products
Reactiona
Total Products
Characterized
(L1Hs Elements)b
Flanks Localized
in HGWDc
Localized L1Hs
Elementsd
Primate-Specific
L1se
Novel Dimorphic
L1Hs Elementsf
3′ ATLAS 19 (19) 8 8 0 3
5′ ATLAS 56 (23) 47 23 24 15
Derived from table S2 (online only, at the authors’ Web site).
a Type of ATLAS reaction, 5′ (Ta-1d) specific or 3′ (Ta) specific.
b Total number of ATLAS products characterized; the number of human-specific L1 (L1Hs) elements is shown in
parentheses.
c Number of characterized products for which the flanking genomic sequences could be localized in the HGWD.
d Number of localized insertions that were identified as human specific.
e Number of localized insertions that were identified as primate specific.
f Number of localized human-specific L1 insertions that were novel (i.e., absent from the HGWD).
it Mendelian segregation. To test this hypothesis, we
subjected genomic DNAs from a large three-genera-
tion CEPH family (paternal and maternal grandpar-
ents, parents, and 10 children) to 5′ ATLAS, and 13
loci were analyzed with respect to band presence or
absence. In all cases, the dimorphic bands showed
stable transmission throughout the pedigree (in fig.
5, four examples are indicated by “A”–“D”). Nota-
bly, even though only 13 loci were examined for seg-
regation, each of the 10 children had unique display
patterns, indicating that ATLAS generates individ-
ual-specific “fingerprints.” Finally, in one instance
(AC015617, a novel insertion at 18q22.3), we estab-
lished that the locus showed significant linkage (LOD
score 13.0) to three flanking Ge´ne´thon STR markers
(data not shown), indicating that the presence/absence
pattern observed is not due to an independently seg-
regating paralogous locus.
5′ ATLAS Can Identify Genetic Variation Associated
with a Subset of Older, Primate-Specific L1s
In 24 of 47 instances, the dimorphic 5′ ATLAS display
products contained older, primate-specific full-length L1s
(from the L1PA2, L1PA3, L1PA4, L1PA7, L1PA8, or L1P
subfamilies [Smit et al. 1995]) and their respective 5′ flank-
ing DNA sequences. This result was unexpected, since
previous studies would predict that these older L1s should
be fixed with respect to presence in human DNA. Thus,
we hypothesized that sequence-specific variants or SNPs
could explain why these display products appeared to be
dimorphic.
To demonstrate conclusively that 5′ ATLAS could se-
lectively amplify a subset of older L1s, we analyzed nine
invariant 5′ display products that were present in all 10
DNAs examined in figure 3b. Sequence analysis revealed
that each invariant band originated from a member of
an older, primate-specific L1 subfamily (L1PA2, L1PA3,
L1PA4, L1PA7, and L1P) that contained an exact match
to the Ta-1d primer sequence (data not shown). Thus,
5′ ATLAS can identify a subset of older L1s that for-
tuitously harbor a Ta-1d primer-binding site.
We next PCR amplified an apparently dimorphic older
L1 (AL157765) from the DNAs of each individual rep-
resented in the CEPH family and analyzed its sequence
in detail (figs. 6a and 6b). Individuals exhibiting a dis-
play product had an allele, of the older L1, that con-
tained a SNP, resulting in a perfect match to the Ta-1d
primer (this SNP also is present in dbSNP [rs2503417]).
In contrast, individuals lacking the display product con-
tained two alleles, of the older L1, that lack that SNP
(fig. 6b). Thus, our data demonstrate that 5′ ATLAS is
exquisitely sensitive and can discriminate between L1
alleles that differ by 1 bp. Notably, similar results were
obtained for two other L1s (AL133391 and AC066611),
and additional product characterization revealed that
the apparent dimorphism in AC093527 was due to a
1-bp insertion/deletion polymorphism within the am-
plified product. Moreover, we conclude that the appar-
ent dimorphism observed in AC011302 likely is due to
a deletion or mutation that eliminates one of the primer-
annealing sites, because the L1 could be amplified only
from individuals harboring the ATLAS display product
(see table S2 [online only, at the authors’ Web site]).
We next wished to determine why the other 19 older
L1s appeared to be dimorphic. As above, in seven in-
stances, analysis of the HGWD revealed that the older
L1 contained at least one nucleotide difference from the
5′ Ta-1d primer used in the ATLAS reaction. However,
in 12 instances, the L1 in the HGWD matched to the
Ta-1d primer-annealing site and is flanked by the re-
striction site used in library construction. Moreover, se-
quence analysis showed that these 12 L1s were not mo-
saic elements that consisted of the 5′ end of a young L1
and the 3′ end of an older L1 (data not shown).
To determine the reason for the apparent dimorphism
associated with these 12 older L1s, we attempted to am-
plify the candidate loci by using PCR primers that flanked
both the restriction site used in library construction and
the Ta-1d primer-annealing site (e.g., see the placement
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Table 3
Characterization of Dimorphic Full-Length L1s Identified by ATLAS
Accession
Numbera
Chromosomal
Locationb
Presence
in HGWDc
Identity to L1.3d
(%)
Retrotransposition
Activitye
Insertion Allele
Frequencyf
Population
Distributiong
AC005885 12q24.32  99.7 ND .63 U
AC044907 15q25.2  99.6 ND .43 U
AC009414 2p22.2  100.0  .32 U
AL121819 14q23.1  99.3  .24 U
AC008826h 5p13.3  99.8 / .16 U
AL358779 9q31.3  99.1  .09 U
AC011092 11p15.3  99.2  .07 AS/NE/SA
AC087224 18q21.2  99.2 / .01 NE
AL021407i 6p22.3  99.3  .0 P
a GenBank accession number of each genomic locus.
b Chromosomal location of each L1 as determined using the HGWD BLAT server.
c Whether the L1 is present () or absent () in the HGWD.
d Percent nucleotide identity to a known Ta-1d L1 (L1.3 [GenBank accession number L19088]).
e Relative retrotransposition activity as compared to L1.3.  p L1s that retrotransposed at ∼50%–100% the level of
L1.3;  p L1s that do not retrotranspose; / p L1s that show marginal activity and retrotransposed at !1% the level of L1.3;
ND p not tested.
f Insertion allele frequency of the respective filled sites in 90 unrelated individuals from four worldwide populations.
g Population distribution of the L1s. U p ubiquitous; AS p restricted to Asians; NE p northern Europeans; SA p South
Americans.
h AC008826 has been replaced with AC016613 in the June 2, 2002, freeze.
i The AL021407 insertion apparently is private to the individual in whom it was discovered.
of primers A and B in fig. 6a). Six loci were amplified
efficiently. In two instances, we could not design locus-
specific primers, because the 5′ flanking sequence was em-
bedded in repeated DNA. In four instances, the designed
primers failed to give specific amplification of the L1,
despite extensive optimization (data not shown).
PCR and sequencing analysis demonstrated that
four loci (AC022884, AL360002, AC087714, and
AL583822) were present in the DNAs from all 10 in-
dividuals examined (i.e., even those who apparently
lacked the L1). However, the sizes of those products
were smaller than expected, indicating that the cloned
L1 did not represent the dimorphic display product but
instead was derived from a faster-migrating invariant
product that appeared at the expected position on the
display gel. Fortunately, this limitation of the gel-res-
olution system can be overcome by simple modifica-
tions of the ATLAS procedure, as we showed by cloning
the authentic dimorphic L1s from two of the above
samples (for details, see the “Discussion” section).
Finally, in two instances (AL160032 and AC93265),
the display products showed dimorphism between pe-
ripheral-blood DNA (band absent) and tumor DNA
(band present) derived from anonymous patients with
Wilms tumor. Direct sequencing of the PCR products
confirmed that both sets of DNA had an identical L1 of
the predicted size. However, because the original ATLAS
library was made using AciI, which is sensitive to CpG
methylation status, the apparent dimorphism likely is
due to hypomethylation of the L1 promoter in tumor
DNA (Alves et al. 1996; Florl et al. 1999; Takai et al.
2000). Thus, unexpectedly, our initial analysis suggests
that ATLAS can detect epigenetic changes associated
with L1s.
Discussion
We have combined the principles employed in L1 display
(Sheen et al. 2000) and suppression PCR (Lavrentieva
et al. 1999; Buzdin et al. 2002; Mamedov et al. 2002),
to develop ATLAS, and we have demonstrated that this
improved system provides a rapid and robust means to
assess genetic variation associated with human L1s.
ATLAS can selectively identify dozens of human-specific
L1s in a single reaction and is superior to L1 display,
which allows for the acquisition of only a few dimorphic
L1s per experiment and requires the use of multiple
primers, low-resolution agarose gel electrophoresis, and
Southern blotting, to detect dimorphic insertions (Sheen
et al. 2000). Moreover, we predict that simple technical
modification, such as the use of fluorescent-labeled prim-
ers and the separation of the ATLAS display products on
automated DNA sequencers, will enable high-throughput
identification of more dimorphic L1s.
In the course of developing ATLAS, we compiled an
extensive database (available online, at the authors’ Web
site) of full-length human-specific L1s from the HGWD.
These L1s were multiply aligned to assess the variation
that exists around known subfamily-specific sequence
variants, allowing us to design primers that would se-
lectively amplify the majority of Ta-subfamily L1s pres-
ent in the HGWD (the alignment is also available online,
at the authors’ Web site). Interestingly, we identified sev-
eral pre-Ta–subfamily and non-Ta–subfamily L1s that
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Figure 4 Dimorphic Ta-1d L1s, identified by 5′ ATLAS. a, Independent assay to assess the dimorphic status of Ta-1d L1s. PCR typing
assays were developed to confirm the presence (filled)/absence (empty) status of Ta-1d L1s identified in the 5′ ATLAS reactions shown in panel
b. Empty sites, lacking the L1 insertion, can be amplified with primers flanking the insertion site (e.g., RB907A and RB907B). Filled sites,
containing the L1 insertion, can be amplified with a Ta-subfamily–specific L1 3′ UTR primer and a 3′ flanking primer (e.g., RB3PA and RB907B).
b, Results of PCR typing experiments. Top, Amplification of empty site through PCR typing by use of the RB907A and RB907B primers.
Bottom, Amplification of filled site through PCR typing by use of the RB3PA and RB907B primers. Note that individual DNA samples (1–10)
can be homozygous for the presence of the L1 (F/F; lanes 2, 8, and 9), heterozygous (EF; lanes 1, 4, 5, and 7), or homozygous for the absence
of the L1 (E/E; lanes 3, 6, and 10). The 11th reaction (Ctrl) is a control PCR with genomic DNA omitted. MW p molecular weight markers.
contain intact ORFs (table 1), some of which remain
retrotransposition competent (Brouha et al., in press).
Clearly, modifications of the L1-specific primers used in
the ATLAS protocol should allow for an assessment of
the variation associated with pre-Ta and other primate-
specific L1 subfamilies.
We have showed that ATLAS identified 18 recent hu-
man-specific L1 insertions that are absent from current
genome databases. Indeed, the ease with which we iso-
lated low-allele-frequency L1 insertions (in three cases;
see the “Results” section) suggests that young L1s are
far more common in human populations than previ-
ously suspected. Thus, although the HGWD provides
a valuable resource to identify human-specific L1s, it
only provides a “snapshot” of extant L1 diversity.
Our data also demonstrate that a subset of primate-
specific L1s share fortuitous sequence identity with the
Ta-1d–specific primer-annealing site. As expected, many
of these L1s were identified as invariant 5′ ATLAS display
products; however, we did identify 24 older L1s that
appeared to be dimorphic. In 14 instances, detailed anal-
yses of the display products revealed the reason for the
apparent dimorphism. In 12 cases, the older L1s accu-
mulated base-substitution polymorphisms within the
Ta-1d primer-annealing site (in 10 cases), contained size
polymorphisms within the amplified product (in 1 case),
or likely contained a deletion or mutation resulting in
the loss of one of the primer-annealing sites (in 1 case).
Similarly, in two other instances, the apparent dimor-
phism likely reflects methylation differences in the L1
promoter that exist between the peripheral-blood and
tumor DNA samples from patients with Wilms tumor.
Thus, we conclude that these 14 older L1s truly are fixed
with respect to presence and that their apparent dimor-
phism results from DNA mutations or epigenetic differ-
ences associated with the L1s.
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Figure 5 ATLAS products’ segregation in families. 5′ Ta-1d–specific ATLAS was performed on a three-generation CEPH pedigree (1331).
FF p paternal grandfather; FM p paternal grandmother; F p father; S/D p son/daughter; M p mother; MF p maternal grandfather; MM
p maternal grandmother. “C1” denotes a control sample in which water was substituted for genomic DNA at digestion; “C2” denotes a
control sample in which water was substituted for library DNA; and “C3” and “C4” denote control samples in which water was substituted
for the primary PCR products in the labeling reaction. Arrows (“A”–“D”) indicate dimorphic array products. MWpmolecular weight markers.
In four instances, we did not clone the actual dimor-
phic L1 but instead mistakenly cloned a minor product
that contained a fixed, anomalously migrating older L1.
Thus, we must conclude that the rapid-acquisition strat-
egy used to characterize display products occasionally
can result in product misidentification. Fortunately, this
minor problem, which is due to a limitation of the gel-
resolution system, can be overcome easily by using DNA
fingerprinting to rapidly identify the “majority product”
present in multiple, independent clones derived from a
given display product. Alternatively, clones can be ob-
tained from the filled or empty sites of different indi-
viduals; L1s that are present only at the filled position
would represent the authentic dimorphic product. In-
deed, in samples in which AL360002 and AC022884
originally were identified as anomalously migrating dis-
play products, the above strategies successfully led to
the identification of AL512410 and AL155765 as the
authentic dimorphic products (see table S2 [online only,
at the authors’ Web site]).
In a final six instances, we could not independently
reamplify the older L1; thus, we could not determine the
actual reason for the apparent dimorphism. Parsimony
would dictate that virtually all of these older L1s also
are fixed with respect to presence and that their appar-
ent dimorphism is due to either DNA mutations associ-
ated with the L1s or product misidentification (as seen
above). However, it is possible that a subset of older L1s
appear to be dimorphic because of gene-conversion
events, between different L1 subfamilies, that could effec-
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Figure 6 Use of ATLAS to identify SNPs within older L1s. a, Segregation of a dimorphic 5′ (Ta-1d) ATLAS product in CEPH family
1331. A dimorphic 5′ ATLAS display product (see “D” in fig. 5) is shown. b, Identification, through sequencing, of a cosegregating SNP at the
L1 primer site. Primers placed outside the AseI restriction site and Ta-1d L1 primer-annealing site enabled PCR amplification of the product
from each individual (1–16) in CEPH family 1331. Direct sequencing of the products revealed that an ATLAS display product occurred only
when an individual inherited an allele, of the L1, containing an exact match to the Ta-1d primer-annealing site. Individuals 3 and 5 are
heterozygous for the matched/mismatched sequence (arrows indicate the double G/C peak). In contrast, individuals 10 and 14 are homozygous
for the mismatched allele (arrows indicate the single G peak).
tively eliminate primer-annealing sites (Kass et al. 1995;
Saxton et al. 1998; Myers et al. 2002). Alternatively, it
is formally possible that dimorphisms result from the
existence of deletion alleles, which encompass the loca-
tion of the display product, although such instances likely
would be rare (Edwards et al. 1992). Notably, either of
the above explanations may account for the results ob-
served with AC0110302 (see the “Results” section and
table S2 [online only, at the authors’ Web site]). None-
theless, taken together, our data demonstrate that ATLAS
is an exquisitely sensitive method for the identification
of genetic variation associated with L1s.
ATLAS now provides a genomic tool to learn even
more about L1 biology. For example, it can be used
to conduct high-throughput screens for human-specific
dimorphic L1s in geographically diverse populations.
Such screens will enable the identification of identical-
by-descent markers of a known ancestral state that will
be useful tools in the study of human population ge-
netics and demography. Similarly, our initial analyses
suggest that epigenetic variation associated with L1s
can be ascertained by using enzymes, in the construc-
tion of ATLAS libraries, that differentially cleave meth-
ylated and unmethylated genomic DNA.
Finally, the reproducibility and individual-specific
nature of ATLAS display patterns suggests that ATLAS
could be employed to study de novo L1 retrotranspo-
sition in small pools of sperm-derived DNA. Similar-
ly, the individual-specific fingerprints that are generat-
ed suggest that ATLAS may be applicable to forensic
situations in which only small amounts of degraded
DNA are available for identification purposes. Indeed,
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the large number of independently segregating markers
and the rarity of reversion make the probability of
misidentification extremely small.
In closing, ATLAS provides a powerful means to iden-
tify genetic variation associated with L1 retrotranspo-
sons. Indeed, our data indicate that, in human popu-
lations, there exist numerous L1s that are absent from
current sequence databases. The ability to rapidly iden-
tify these L1s will lead to a greater appreciation of how
they continue to sculpt our genome.
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